- Primary menu
- Home
- Publish With Us
- Contributors
- About Us
- Contact Us
- Advertise
- Sign Up For NLR Bulletins
- QUICK LINKS
- Antitrust Law
- |
- Bankruptcy & Restructuring
- |
- Biotech & Cleantech
- |
- Business of Law
- |
- Election
- Construction & Real Estate
- |
- Environmental, Energy & Resources
- |
- Financial, Securities & Banking
- Health Care
- |
- Immigration
- |
- IP Law
- |
- Insurance
- |
- Labor & Employment
- |
- Litigation
- |
- Media & FCC
- |
- Tax
HIPAA Webinar Series - Part II: Research, Marketing & Sales
|
Webinar
Drinker Biddle & Reath LLP
Tuesday, April 9, 2013 - 11:30am - 12:30pm
Administrative & Regulatory / Consumer Protection / Health Law & Managed Care
All Federal
|
HIPAA Webinar Series
Join Drinker Biddle’s Government Relations and Health Care panel to learn about the implications of the Health Insurance Portability and Accountability Act (HIPAA) Omnibus Final Rule.
Part II: Research, Marketing & Sales
This webinar will review the new options for streamlining research authorizations and provide clarification regarding the specificity needed in research authorizations to allow for future research uses of protected health information (PHI). The panel also will discuss the new restrictions on use and disclosure of PHI for marketing purposes and how these will impact covered entities and vendors alike.
April 9, 2013
- 11:30 a.m. - 12:30 p.m. CT / 12:30 p.m. - 1:30 p.m. ET
Presented by:
- Peter Blenkinsop, Associate
- Julie Rusczek, Associate
- Robyn Shapiro, Partner
Related Articles
- Tools for the Trade: Understanding Health Insurance Portability and Accountability Act of 1996 (HIPAA)
- POM Wonderful – Where Are We Now? Re: Federal Trade Commission (FTC) and Deceptive Advertising
- Years Later, Peanut Corporation of America (PCA) Employees Indicted
- HIPAA Omnibus Rule Effective March 26, 2013
- HIPAA Omnibus Final Rule Effective Today, March 26, 2013
- Food and Drug Administration (FDA) Uses New Recall Power for First Time
- Bronchiolitis Obliterans Claims Expand to New Industries
- FDA Flexes Its FSMA Muscles, Initiates Mandatory Recall
Advertisement
Recent Contributions to the National Law Review
Barnes & Thornburg LLP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Raymond Law Group LLC
Sheppard, Mullin, Richter & Hampton LLP
Greenberg Traurig, LLP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Womble Carlyle Sandridge & Rice, PLLC
Neal, Gerber & Eisenberg LLP
McDermott Will & Emery
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Lowndes, Drosdick, Doster, Kantor & Reed, P.A.
Womble Carlyle Sandridge & Rice, PLLC
Dinsmore & Shohl LLP
McDermott Will & Emery
Giordano, Halleran & Ciesla, P.C.
Allen Matkins Leck Gamble Mallory & Natsis LLP
Andrews Kurth LLP
Raymond Law Group LLC
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Womble Carlyle Sandridge & Rice, PLLC






